Puls K, Wolber G
Molecules. 2023; 28(2).
PMID: 36677775
PMC: 9861206.
DOI: 10.3390/molecules28020718.
Chakraborty S, Majumdar S
Biochemistry. 2020; 60(18):1381-1400.
PMID: 32930582
PMC: 7982354.
DOI: 10.1021/acs.biochem.0c00629.
Zjawiony J, Machado A, Menegatti R, Ghedini P, Costa E, Pedrino G
Front Psychiatry. 2019; 10:157.
PMID: 30971961
PMC: 6445891.
DOI: 10.3389/fpsyt.2019.00157.
Roach J, Shenvi R
Bioorg Med Chem Lett. 2018; 28(9):1436-1445.
PMID: 29615341
PMC: 5912166.
DOI: 10.1016/j.bmcl.2018.03.029.
Lee D, Deng G, Ma Z, Xu W, Yang L, Liu J
Bioorg Med Chem Lett. 2015; 25(20):4689-92.
PMID: 26330078
PMC: 4620681.
DOI: 10.1016/j.bmcl.2015.06.092.
Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
Polepally P, White K, Vardy E, Roth B, Ferreira D, Zjawiony J
Bioorg Med Chem Lett. 2013; 23(10):2860-2.
PMID: 23587424
PMC: 3651692.
DOI: 10.1016/j.bmcl.2013.03.111.
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham C, Rothman R, Prisinzano T
Pharmacol Rev. 2011; 63(2):316-47.
PMID: 21444610
PMC: 3082450.
DOI: 10.1124/pr.110.003244.
Unusual hemiacetal structure derived from Salvinorin A.
Carvalho P, Bikbulatov R, Zjawiony J, Avery M
Acta Crystallogr Sect E Struct Rep Online. 2011; 64(Pt 7):o1370-1.
PMID: 21202988
PMC: 2961764.
DOI: 10.1107/S160053680800144X.
CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity.
McGovern D, Mosier P, Roth B, Westkaemper R
J Mol Graph Model. 2010; 28(7):612-25.
PMID: 20083418
PMC: 2859180.
DOI: 10.1016/j.jmgm.2009.12.008.
Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.
McClatchey W, Mahady G, Bennett B, Shiels L, Savo V
Pharmacol Ther. 2009; 123(2):239-54.
PMID: 19422851
PMC: 2700180.
DOI: 10.1016/j.pharmthera.2009.04.002.
Synthesis of deacetyl-1,10-didehydrosalvinorin G.
Ma Z, Lee D
Tetrahedron Lett. 2009; 49(11):1782-1785.
PMID: 19279674
PMC: 2390901.
DOI: 10.1016/j.tetlet.2008.01.065.
Short synthesis of a novel class of salvinorin A analogs with hemiacetalic structure.
Bikbulatov R, Stewart J, Jin W, Yan F, Roth B, Ferreira D
Tetrahedron Lett. 2009; 49(6):937-940.
PMID: 19197341
PMC: 2344139.
DOI: 10.1016/j.tetlet.2007.12.041.
Revised structure of deacetyl-1,10-didehydrosalvinorin G.
Ma Z, Lee D
Tetrahedron Lett. 2008; 48(31):5461-5464.
PMID: 18665199
PMC: 2390872.
DOI: 10.1016/j.tetlet.2007.05.179.
Salvinorin A analogs as probes in opioid pharmacology.
Prisinzano T, Rothman R
Chem Rev. 2008; 108(5):1732-43.
PMID: 18476672
PMC: 2648615.
DOI: 10.1021/cr0782269.
Endogenous opiates and behavior: 2006.
Bodnar R
Peptides. 2007; 28(12):2435-513.
PMID: 17949854
PMC: 2693002.
DOI: 10.1016/j.peptides.2007.09.002.
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore.
Balboni G, Onnis V, Congiu C, Zotti M, Sasaki Y, Ambo A
Bioorg Med Chem. 2007; 15(9):3143-51.
PMID: 17339114
PMC: 2377021.
DOI: 10.1016/j.bmc.2007.02.039.
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.
Bikbulatov R, Yan F, Roth B, Zjawiony J
Bioorg Med Chem Lett. 2007; 17(8):2229-32.
PMID: 17303418
PMC: 1905843.
DOI: 10.1016/j.bmcl.2007.01.100.
8-epi-Salvinorin B: crystal structure and affinity at the kappa opioid receptor.
Munro T, Duncan K, Staples R, Xu W, Liu-Chen L, Beguin C
Beilstein J Org Chem. 2007; 3:1.
PMID: 17212822
PMC: 1805503.
DOI: 10.1186/1860-5397-3-1.